1. Cross PCA, Giles T, Johnson S, Kocjan G, Poller D, Stephenson T. Guidance on the reporting of thyroid cytology specimens. Royal College of Pathologists; 2009.
2. Guidelines for the Management of Thyroid Cancer. 2007. http://www.british-thyroid-association.org/news/Docs/Thyroid_cancer_guidelines_2007.pdf.
3. Cross P, Chandra A, Giles T, Johnson S, Kocjan G, Poller D, et al. Guidance on the reporting of thyroid cytology specimens. 2nd ed. Royal College of Pathologists; 2016.
4. Cross P, Chandra A, Giles T, Johnson S, Poller D. Guidance on the reporting of thyroid cytology specimens. 3rd ed. Royal College of Pathologists; 2022.
5. van der Horst C, Wright S, Young D, Tailor H, Clark L. What is Thy3a? A study of 336 Thy3a (AUS/FLUS) thyroid FNAs with histology compares UK RCPath with other reporting systems and shows how Thy3a subclassification can improve risk stratification and help address overuse of this category. Cytopathology. 2020;32:29. https://doi.org/10.1111/cyt.12910.